A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...

Gold dust in eyes might seem like an unusual therapy – but a new mouse study in the US shows the approach could potentially ...

Heart attacks remain a significant health concern in the United States. According to the Centers for Disease Control and ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and ...

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

Authors of the study believe this potential will provide clinicians with valuable information about patient responses to treatment.

Scientists have developed a powerful new injectable treatment that, when administered after a heart attack, helps the heart ...

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

photodynamic therapy with verteporfin and surgical treatments. Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration ...

The complete response letter did not identify any issues with the safety or efficacy of Eylea HD, Regeneron officials said.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart ...